Filing Details

Accession Number:
0001062993-24-006109
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-03-11 16:04:29
Reporting Period:
2024-03-07
Accepted Time:
2024-03-11 16:04:29
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
842023 Bio-Techne Corp TECH Biological Products, (No Disgnostic Substances) (2836) 411427402
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1492695 Roeland Nusse 614 Mckinley Pl Ne
Minneapolis MN 55413
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-03-07 10,400 $76.98 43,097 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Options (Right to Buy) $21.84 2016-10-29 2025-10-28 17,040 17,040 Direct
Common Stock Stock Options (Right to Buy) $25.30 2017-10-26 2026-10-27 15,940 15,940 Direct
Common Stock Stock Options (Right to Buy) $31.26 2018-10-25 2027-10-26 12,500 12,500 Direct
Common Stock Stock Options (Right to Buy) $44.96 2019-10-24 2028-10-25 7,592 7,592 Direct
Common Stock Stock Options (Right to Buy) $50.41 2020-10-24 2029-10-24 8,044 8,044 Direct
Common Stock Stock Options (Right to Buy) $63.92 2021-10-28 2030-10-29 6,028 6,028 Direct
Common Stock Stock Options (Right to Buy) $128.81 2022-10-27 2031-10-28 2,532 2,532 Direct
Common Stock Stock Options (Right to Buy) $73.94 2023-10-26 2032-10-27 3,460 3,460 Direct
Common Stock Stock Options (Right to Buy) $61.51 2033-10-26 3,937 3,937 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2025-10-28 17,040 17,040 Direct
2026-10-27 15,940 15,940 Direct
2027-10-26 12,500 12,500 Direct
2028-10-25 7,592 7,592 Direct
2029-10-24 8,044 8,044 Direct
2030-10-29 6,028 6,028 Direct
2031-10-28 2,532 2,532 Direct
2032-10-27 3,460 3,460 Direct
2033-10-26 3,937 3,937 Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.955 to $77.11, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  2. The option vests on the earlier of the one year anniversary of the grant date (10/26/2023) or the date of Bio-Techne's 2024 annual meeting of shareholders.